...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.
【24h】

Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.

机译:由面筋刺激的乳糜泻特异性肠T细胞释放的干扰素-γ增强了面筋肽的上皮通量。

获取原文
获取原文并翻译 | 示例
           

摘要

Celiac sprue is a T-cell-mediated enteropathy elicited in genetically susceptible individuals by dietary gluten proteins. To initiate and propagate inflammation, proteolytically resistant gluten peptides must be translocated across the small intestinal epithelium and presented to DQ2-restricted T cells, but the effectors enabling this translocation under normal and inflammatory conditions are not well understood. We demonstrate that a fluorescently labeled antigenic 33-mer gluten peptide is translocated intact across a T84 cultured epithelial cell monolayer and that preincubation of the monolayer with media from gluten-stimulated, celiac patient-derived intestinal T cells enhances the apical-to-basolateral flux of this peptide in a dose-dependent, saturable manner. The permeability-enhancing activity of activated T-cell media is inhibited by blocking antibodies against either interferon-gamma or its receptor and is recapitulated using recombinant interferon-gamma. At saturating levels of interferon-gamma, activated T-cell media does not further increase transepithelial peptide flux, indicating the primacy of interferon-gamma as an effector of increased epithelial permeability during inflammation. Reducing the assay temperature to 4 degrees C reverses the effect of interferon-gamma but does not reduce basal peptide flux occurring in the absence of interferon-gamma, suggesting active transcellular transport of intact peptides is increased during inflammation. A panel of disease-relevant gluten peptides exhibited an inverse correlation between size and transepithelial flux but no apparent sequence constraints. Anti-interferon-gamma therapy may mitigate the vicious cycle of gluten-induced interferon-gamma secretion and interferon-gamma-mediated enhancement of gluten peptide flux but is unlikely to prevent translocation of gluten peptides in the absence of inflammatory conditions.
机译:腹腔灌肠是一种由T细胞介导的肠病,由饮食中的麸质蛋白在遗传易感人群中引发。为了引发和传播炎症,必须将蛋白水解抗性面筋肽转运至小肠上皮并转运至DQ2限制性T细胞,但对于在正常和炎症条件下能实现该转运的效应子,人们尚不清楚。我们证明了荧光标记的抗原性33-mer麸质肽原封不动地跨过T84培养的上皮细胞单层转运,并且该单层与谷蛋白刺激的,腹腔病人来源的肠T细胞的培养基一起预孵育增强了根尖到基底外侧的通量以剂量依赖,可饱和的方式制备该肽。活化的T细胞培养基的通透性增强活性受阻断抗干扰素γ或其受体的抗体的抑制,并使用重组干扰素γ概括。在干扰素-γ的饱和水平下,活化的T细胞培养基不会进一步增加跨上皮肽通量,这表明干扰素-γ作为炎症过程中上皮通透性增加的效应子至关重要。将测定温度降低至4摄氏度可逆转干扰素-γ的作用,但不会降低不存在干扰素-γ时发生的基础肽通量,表明在炎症过程中完整肽段的主动跨细胞转运增加了。一组与疾病相关的谷蛋白肽在大小和上皮通量之间显示出负相关,但没有明显的序列限制。抗干扰素-γ疗法可以减轻面筋诱导的干扰素-γ分泌的恶性循环和干扰素-γ介导的面筋肽通量的增强,但在没有炎症的情况下不可能阻止面筋肽的移位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号